Increased urinary cortisol levels during the menopause transition
Authors:
- Nancy F. WoodsNWNancy F. Woods
- Molly C. CarrMCMolly C. Carr
- Eunice Y. TaoETEunice Y. Tao
- Heather J. TaylorHTHeather J. Taylor
- Ellen S. MitchellEMEllen S. Mitchell
- 1 March 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 13 (2) , 212-221
Abstract
To determine whether cortisol levels change prospectively during the menopausal transition (MT); whether these changes are associated with changes in the hypothalamic-pituitary-ovarian axis (follicle-stimulating hormone [FSH] and estrone glucuronide [E1G]), stressors, or menopause symptoms; and whether women who experienced a rise in cortisol levels during the transition had behavioral practices, stressors, vasomotor symptoms, or mood or sleep disturbances that affected hypothalamic-pituitary-adrenal axis function. One hundred sixty-nine women in the middle or late MT or early postmenopause stages provided monthly urine specimens for cortisol, FSH, and E1G, and rated symptoms and stress levels as part of a longitudinal study of the MT. Of these women, 91 completed a transition to the next MT stage: from early to middle (n = 30), middle to late (n = 39), or late to postmenopause (n = 22) and were eligible for inclusion in the analyses. Cortisol increased from 7 to 12 months before the late MT stage to 7 to 12 months after onset of the late MT stage. There were no differences before and after the middle MT stage or the final menstrual period. Women with increased cortisol (>10 ng/mg creatinine) during the late MT stage had more severe vasomotor symptoms than those without changes, but did not differ in terms of age, body mass index, levels of FSH or E1G, health practices, exercise, mood, sleep, cognition, or stress levels. Cortisol levels rise with age, but have not been linked to stages of the MT. Increased cortisol levels during the late MT stage, when menstrual irregularities are greatest, suggests increases in adrenal androgens and intraabdominal fat with menopause, and may influence risk of cardiovascular disease, vasomotor symptoms, mood, cognition, and bone loss.Keywords
This publication has 26 references indexed in Scilit:
- The Relationship of Circulating Dehydroepiandrosterone, Testosterone, and Estradiol to Stages of the Menopausal Transition and EthnicityThe Journal of Clinical Endocrinology & Metabolism, 2002
- Physiologic Markers of Chronic Stress in Premenopausal, Middle-Aged WomenPsychosomatic Medicine, 2002
- Ovarian Function in Late Reproductive Years in Relation to Lifetime Experiences of AbuseEpidemiology, 2001
- Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and womenJournal of Internal Medicine, 2000
- The Relation Between Cortisol Excretion and Fractures in Healthy Older People: Results from the MacArthur Studies ‐ MacJournal of the American Geriatrics Society, 1999
- Aging and the adrenal cortexExperimental Gerontology, 1998
- The Neurobiology of Stress: Understanding Regulation of Affect During Female Biological TransitionsSeminars in Reproductive Medicine, 1997
- Stress in Employed WomenPsychosomatic Medicine, 1997
- Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction.Journal of Clinical Investigation, 1993
- Source of Estrogen Production in Postmenopausal Women1The Journal of Clinical Endocrinology & Metabolism, 1973